Inhibition of nuclear factor-kappaB activation improves the survival of rats with taurocholate pancreatitis

Gut. 1999 Feb;44(2):253-8. doi: 10.1136/gut.44.2.253.

Abstract

Background: Death in the early stages of severe acute pancreatitis is frequently the result of multiple organ dysfunction, but its mechanism is not clear.

Aims: To investigate the state of nuclear factor-kappaB (NF-kappaB) in macrophages of rats with lethal pancreatitis, and to assess the effectiveness of pyrrolidine dithiocarbamate, an inhibitor of NF-kappaB, on the pathology and mortality.

Methods: Taurocholate pancreatitis was produced in rats, and the severity of the disease, the mortality, and activation of NF-kappaB in peritoneal and alveolar macrophages were compared in rats receiving pyrrolidine dithiocarbamate (PDTC) treatment and those that were not.

Results: Taurocholate pancreatitis produced massive necrosis, haemorrhage, and severe leucocyte infiltration in the pancreas as well as alveolar septal thickening in the lung. NF-kappaB was activated in peritoneal and alveolar macrophages six hours after pancreatitis induction. Pretreatment with PDTC dose-dependently attenuated the NF-kappaB activation and improved the survival of the rats, although it did not affect the early increase in serum amylase and histological findings.

Conclusions: Early blockage of NF-kappaB activation may be effective in reducing fatal outcome in severe acute pancreatitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Animals
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use*
  • Dose-Response Relationship, Drug
  • Macrophages, Alveolar / metabolism
  • Macrophages, Peritoneal / metabolism
  • Male
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / metabolism
  • Pancreatitis / chemically induced
  • Pancreatitis / drug therapy*
  • Pancreatitis / genetics
  • Pyrrolidines / pharmacology
  • Pyrrolidines / therapeutic use*
  • Rats
  • Survival Rate
  • Taurocholic Acid
  • Thiocarbamates / pharmacology
  • Thiocarbamates / therapeutic use*

Substances

  • Antioxidants
  • NF-kappa B
  • Pyrrolidines
  • Thiocarbamates
  • pyrrolidine dithiocarbamic acid
  • Taurocholic Acid